Medline Inc Ordinary Shares - Class A

MDLN: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
lXLOCK|JX<F>LOCK|^%cp^^

Medline Earnings: Strong Revenue Not Enough to Stop Selloff as Margin Uncertainty Rises

Medline reported 11% revenue growth, above FactSet consensus, and a 250-basis-point contraction in adjusted EBITDA margin for the first quarter. Organic sales guidance was inched up 50 basis points. The shares were down 9% intraday on May 6.

Sponsor Center